Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and...
14 Oct, 2025 | 07:10pm • Source: BSE
Jubilant Pharmova Limited has informed the Exchange about General Updates - Press Release pertaining to the launch of New High-Speed Isolator based Line, at its...
10 Oct, 2025 | 09:45am • Source: NSE
Intimation under Reg 30 - Launch of New High Speed Isolator base line at its Spokane Manufacturing Facility in US by Jubilant HollisterStier LLC
10 Oct, 2025 | 08:03am • Source: BSE
Submission of communication email sent to shareholders whose dividend(s) remains unpaid pursuant to "Saksham Niveshak - 100 Days Campaign"
08 Oct, 2025 | 08:20pm • Source: BSE
Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
07 Oct, 2025 | 04:55pm • Source: BSE
Copy of Newspaper Publication
01 Oct, 2025 | 11:35pm • Source: BSE
Allotment of Optionally Convertible Redeemable Non-Cumulative Preference Shares(OCRPS) by Jubilant Biosys Limited, a wholly owned subsidiary Company
01 Oct, 2025 | 01:29pm • Source: BSE
Appointment of CFO of the Company
23 Sep, 2025 | 11:40am • Source: BSE
Outcome of Board Meeting held on September 23, 2025
23 Sep, 2025 | 11:38am • Source: BSE
Disclosure under Regulation 30 - Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Obervations
20 Sep, 2025 | 08:35pm • Source: BSE
Reminder email sent to shareholders intimating about the 100 days campaign
12 Sep, 2025 | 08:02pm • Source: BSE
Disclosure under Regulation 30 - Receipt of Orders passed by the Additional Commissioner Central Tax (Appeals), Mysuru
02 Sep, 2025 | 11:42pm • Source: BSE
Disclosure under Regulation 30 - Completion of Sale and Transfer of API Business
01 Sep, 2025 | 11:42pm • Source: BSE
Jubilant Pharmova Limited has informed the Exchange about change in Management
01 Sep, 2025 | 02:41pm • Source: NSE
Resignation of Senior Management Personnel
01 Sep, 2025 | 01:54pm • Source: BSE
Resignation of Dr. Ramakrishnan Arul, Whole-Time Director of the Company
01 Sep, 2025 | 01:50pm • Source: BSE
Scrutinizer''s Report dated August 29, 2025.
29 Aug, 2025 | 09:46pm • Source: BSE
Proceedings and Voting results of 47th AGM.
29 Aug, 2025 | 09:43pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 18, 2025 for...
19 Aug, 2025 | 11:07am • Source: BSE